Back to search results

Mobile Health Program for Post-Preeclampsia Hypertension

This study is testing a mobile health program for women who have high blood pressure (hypertension) after experiencing a hypertensive disorder during pregnancy (HDP), like preeclampsia or gestational hypertension. The program includes a coaching application and a home blood pressure monitor that connects to your phone. Researchers want to see if this new approach, which also uses the WebMD app for health education, can better control blood pressure compared to standard care. You might be able to join if you are a woman, aged 18 or older, had HDP 10-20 years ago at Magee-Womens Hospital, and currently have stage 2 hypertension (blood pressure 140/90 mmHg or higher). The main goal is to see how much your systolic blood pressure (the top number) changes after 3 months. The current recruitment status is unclear.

Study design
This is an interventional study with a planned enrollment of 50 women. The study aims to compare a mobile health program to standard care.
What's involved
You would use a coaching application, a home blood pressure monitor, and the WebMD app. Your blood pressure will be measured at the start and again at 3 months.
Compensation
Not stated in the trial record.
Follow-up
Your blood pressure will be monitored for 3 months after starting the program.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07599579

Mobile Health Program for Post-Preeclampsia Hypertension

Recruiting
NAAges 18+InterventionalTreatment
University of Pittsburgh
~50 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:Coaching applicationHome-based blood pressure monitoringWebMD

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in systolic blood pressure from baseline to 3 months
Measured over Baseline, 3 Months

Conditions

Hypertension (HTN)
Preeclampsia
Hypertensive Disorders of Pregnancy (HDP)

Explore related trials

HypertensionPreeclampsiaToxemia of Pregnancy

Where it's being run

1 sites across 1 states
Pennsylvania1

Study leadership

  • Malamo Countouris, MD, MS · PRINCIPAL_INVESTIGATOR · University of Pittsburgh

Who to contact

Amy Travis
[email protected]
4126413295
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Women who had a history of HDP (either gestational HTN or preeclampsia) diagnosed by ACOG guidelines at the time of delivery at Magee-Womens Hospital between 2008 and 2015, thus 10 to 20 years from their index pregnancy complicated by HDP.
Evidence of current stage 2 HTN (BP ≥ 140/90 mmHg with or without treatment with antihypertensive medication).

Exclusion

Known clinical CVD (prior myocardial infarction, stroke, heart failure, or peripheral arterial disease).
Males will also be excluded from this study as it focuses on pregnancy related conditions.
Children will be excluded as the study is only recruiting people who are 10-20 years postpartum.

What this trial measures

  • Change in systolic blood pressure from baseline to 3 monthsBaseline, 3 Months

    Change in home-based systolic blood pressure from baseline to 3 months between the intervention and usual care arms.